Introduction:Basic information about CAS 91-75-8|Antazoline, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Antazoline |
|---|
| CAS Number | 91-75-8 | Molecular Weight | 265.353 |
|---|
| Density | 1.1±0.1 g/cm3 | Boiling Point | 475.5±38.0 °C at 760 mmHg |
|---|
| Molecular Formula | C17H19N3 | Melting Point | 159ºC |
|---|
| MSDS | / | Flash Point | 241.4±26.8 °C |
|---|
Names
| Name | antazoline |
|---|
| Synonym | More Synonyms |
|---|
Antazoline BiologicalActivity
| Description | Antazoline is an H1 receptor antagonist that affects the activity of the central nervous system, has a potent antiarrhythmic effect[1][2][3]. |
|---|
| Related Catalog | Signaling Pathways >>Immunology/Inflammation >>Histamine ReceptorResearch Areas >>Neurological DiseaseSignaling Pathways >>GPCR/G Protein >>Histamine Receptor |
|---|
| Target | H1 receptor |
|---|
| In Vitro | Antazoline shows good inhibitory effect on HBV DNA in the supernatant of HepAD38 and Huh7 cells with the value of EC50 is 2.910 μmol/L and 2.349 μmol/L, respectively[2]. Cell Cytotoxicity Assay[2] Cell Line: HepAD38 cells Concentration: 10μmol/L Incubation Time: 5 days Result: Exhibited no significant cytotoxicity at a concentration of 10μmol/L and had a dose-dependent inhibition of HBV DNA in the supernatant. RT-PCR[2] Cell Line: Huh7 cells Concentration: 30 μmol/L, 10 μmol/L, 3.33 μmol/L, 1.1 μmol/L, 0.370 μmol/L, and 0.123 μmol/L Incubation Time: 4 days Result: Had a significant inhibitory effect on HBV DNA in supernatants in a dose-dependent manner. |
|---|
| In Vivo | Antazoline (IP; 0.01 ml/g; 30min) as H1 receptor antagonists diminishes the anticonvulsant activity of carbamazepine and diphenylhydantoin[3]. Animal Model: Swiss mice[3] Dosage: 0.01 mL/g Administration: Antazoline (IP; 0.01 ml/g; 30min) Result: Showed some proconvulsive activity. |
|---|
| References | [1]. Maciej T Wybraniec, et al. Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of a multicenter registry (CANT II Study). Pol Arch Intern Med. 2022 Jun 29;132(6):16234. [2]. Jing Li, et al. Repurposing of Antazoline Hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion. Virol Sin. 2021 Jun;36(3):501-509. [3]. MariuszŚwiąder,et al. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice. Eur Neuropsychopharmacol. 2004 Aug;14(4):307-18. |
|---|
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|
| Boiling Point | 475.5±38.0 °C at 760 mmHg |
|---|
| Melting Point | 159ºC |
|---|
| Molecular Formula | C17H19N3 |
|---|
| Molecular Weight | 265.353 |
|---|
| Flash Point | 241.4±26.8 °C |
|---|
| Exact Mass | 265.157898 |
|---|
| PSA | 27.63000 |
|---|
| LogP | 4.39 |
|---|
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
|---|
| Index of Refraction | 1.608 |
|---|
| InChIKey | REYFJDPCWQRWAA-UHFFFAOYSA-N |
|---|
| SMILES | c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 |
|---|
| Storage condition | -20°C |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- NJ2000000
- CHEMICAL NAME :
- 2-Imidazoline, 2-((N-benzylanilino)methyl)-
- CAS REGISTRY NUMBER :
- 91-75-8
- BEILSTEIN REFERENCE NO. :
- 0233924
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 6
- MOLECULAR FORMULA :
- C17-H19-N3
- MOLECULAR WEIGHT :
- 265.39
- WISWESSER LINE NOTATION :
- T5M CN BUTJ B1N1R&R
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration into the eye
- SPECIES OBSERVED :
- Rodent - rabbit
- REFERENCE :
- OPHTAD Ophtalmologica. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.96- 1978- Volume(issue)/page/year: 143,154,1962 ** ACUTE TOXICITY DATA **
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 398 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 7,237,1957
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. Volume(issue)/page/year: 237,171,1959
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 135 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 17,214,1967
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 61 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 188,189,1970 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M3378 No. of Facilities: 3 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 5 (estimated)
|
Safety Information
| Hazard Codes | Xi |
|---|
| Safety Phrases | S22-S24/25 |
|---|
Synonyms
| Phenazoline |
| 1H-Imidazole-2-methanamine, 4,5-dihydro-N-phenyl-N-(phenylmethyl)- |
| Antistin |
| Histostab |
| Fenazolina |
| Phenazolin |
| Histazine |
| N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)phenylamine |
| EINECS 202-094-0 |
| Antastan |
| Antistine |
| Antazoline |
| Imidamine |
| Antihistal |
| N-Benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline |
| N-Benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-anilin |
| MFCD00047013 |
| Antasten |
| benzyl-(4,5-dihydro-1H-imidazol-2-ylmethyl)-phenyl-amine |
| N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-aniline |
| N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-N-(phenylmethyl)aniline |